当前位置: X-MOL 学术Neuron › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.
Neuron ( IF 16.2 ) Pub Date : 2019-12-16 , DOI: 10.1016/j.neuron.2019.11.019
Colleen A Stoyas 1 , David D Bushart 2 , Pawel M Switonski 3 , Jacqueline M Ward 4 , Akshay Alaghatta 1 , Mi-Bo Tang 5 , Chenchen Niu 1 , Mandheer Wadhwa 1 , Haoran Huang 6 , Alex Savchenko 4 , Karim Gariani 7 , Fang Xie 4 , Joseph R Delaney 1 , Terry Gaasterland 8 , Johan Auwerx 7 , Vikram G Shakkottai 2 , Albert R La Spada 9
Affiliation  

Sirtuin 1 (Sirt1) is a NAD+-dependent deacetylase capable of countering age-related neurodegeneration, but the basis of Sirt1 neuroprotection remains elusive. Spinocerebellar ataxia type 7 (SCA7) is an inherited CAG-polyglutamine repeat disorder. Transcriptome analysis of SCA7 mice revealed downregulation of calcium flux genes accompanied by abnormal calcium-dependent cerebellar membrane excitability. Transcription-factor binding-site analysis of downregulated genes yielded Sirt1 target sites, and we observed reduced Sirt1 activity in the SCA7 mouse cerebellum with NAD+ depletion. SCA7 patients displayed increased poly(ADP-ribose) in cerebellar neurons, supporting poly(ADP-ribose) polymerase-1 upregulation. We crossed Sirt1-overexpressing mice with SCA7 mice and noted rescue of neurodegeneration and calcium flux defects. NAD+ repletion via nicotinamide riboside ameliorated disease phenotypes in SCA7 mice and patient stem cell-derived neurons. Sirt1 thus achieves neuroprotection by promoting calcium regulation, and NAD+ dysregulation underlies Sirt1 dysfunction in SCA7, indicating that cerebellar ataxias exhibit altered calcium homeostasis because of metabolic dysregulation, suggesting shared therapy targets.

中文翻译:

烟酰胺途径依赖性Sirt1激活可恢复钙稳态,从而实现7型脊髓小脑共济失调的神经保护作用。

Sirtuin 1(Sirt1)是一种NAD +依赖性脱乙酰基酶,能够对抗与年龄相关的神经变性,但Sirt1神经保护的基础仍然难以捉摸。脊髓小脑共济失调7型(SCA7)是一种遗传性CAG-聚谷氨酰胺重复性疾病。SCA7小鼠的转录组分析显示钙通量基因下调,并伴有异常的钙依赖性小脑膜兴奋性。转录因子结合位点分析的下调基因产生Sirt1目标位点,并且我们观察到在NAD +耗竭下SCA7小鼠小脑中Sirt1活性降低。SCA7患者显示小脑神经元中的聚(ADP-核糖)增加,支持聚(ADP-核糖)聚合酶-1上调。我们将过量表达Sirt1的小鼠与SCA7小鼠杂交,并注意到神经变性和钙通量缺陷得到了挽救。通过烟酰胺核苷的NAD +补充改善了SCA7小鼠和患者干细胞来源的神经元的疾病表型。因此,Sirt1通过促进钙调节来实现神经保护作用,而NAD +调节异常是SCA7中Sirt1功能障碍的基础,这表明小脑共济失调由于代谢异常而表现出钙稳态的改变,这提示了共同的治疗目标。
更新日期:2019-12-17
down
wechat
bug